New antibiotic studied in kids: first step toward better infection treatment
NCT ID NCT05217537
First seen Mar 19, 2026 · Last updated Jun 22, 2026 · Updated 9 times
Summary
This early-phase study tested a single dose of the antibiotic omadacycline (Nuzyra) in 23 children aged 8 to 17 who were hospitalized with bacterial infections. Researchers measured how the drug moved through the body and checked for side effects. The goal was to gather safety and dosing information, not to treat the infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Site 105
Chicago, Illinois, 60611, United States
-
Site 106
Cleveland, Ohio, 60611, United States
-
Site 107
Orange, California, 92868, United States
-
Site 108
Houston, Texas, 77030, United States
-
Site 109
Little Rock, Arkansas, 72202, United States
-
Site 111
Greenville, North Carolina, 27858, United States
-
Site 112
Long Beach, California, 90806, United States
-
Site 113
Philadelphia, Pennsylvania, 19104, United States
-
Site 114
Aurora, Colorado, 80045, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
omadacycline (Nuzyra)
What this could lead to
If successful, this could help determine the right dose of omadacycline for children with bacterial infections.
What could go wrong
This is a very early, small study (23 children) that only looked at a single dose. It does not prove the drug works or is safe for long-term use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.